EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

The Therapeutic Effects of Active Components from Food-Medicine Plants on Liver Fibrosis

Caiyun Sun, Binlong Chen, Yaodong Hu, Silu Wang, Ting Chen, Min Xu, Qianyuan Gong iD

Journal of Inflammation Research · 2026-01 · Volume 19 · 1-20

DOI: 10.2147/jir.s573983 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-01. Verfasst von Caiyun Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science, Xichang University, Xichang, 615013, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, a chronic progression process of liver disease in which various factors damage the liver, leading to the development of liver inflammation and eventually progressing to liver cirrhosis. Food-medicine plants, which serve dual roles in nutrition and therapy, play a significant role in the management of chronic diseases, particularly within minority communities and developing regions. This review systematically examines the therapeutic potential of bioactive compounds derived from food-medicine plants-such as flavonoids, alkaloids, phenolics, and terpenoids-in mitigating liver fibrosis. These compounds exert their effects through multiple mechanisms, including modulation of key signaling pathways such as TGF-β, PI3K/Akt, ferroptosis, and Wnt/β-catenin. Additionally, they enhance antioxidant enzyme activity, suppress pro-fibrotic mediators, and reduce fibrosis-related biomarkers. Overall, this work underscores the multifaceted mechanisms underlying the anti-fibrotic effects of food-medicine plant products. Nevertheless, further clinical validation is necessary to translate these preclinical insights into effective therapies, thereby providing a foundation for future research and drug development in the management of liver fibrosis.

Schlagwörter

Stichwörter der Autor:innen

bioactive compoundsfood-medicine plantsliver fibrosisliver inflammation

Autor:innen und Institutionen

  • College of Animal Science, Xichang University, Xichang, 615013, People's Republic of China.
  • Department of Cardiology, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, 610031, People's Republic of China.
  • Medical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, 610031, People's Republic of China.

ORCID-Profile: Qianyuan Gong

Zitieren

APA

Sun, C., Chen, B., Hu, Y., Wang, S., Chen, T., Xu, M., & Gong, Q. (2026). The Therapeutic Effects of Active Components from Food-Medicine Plants on Liver Fibrosis. Journal of Inflammation Research, Volume 19, 1-20. https://doi.org/10.2147/jir.s573983

Vancouver

Sun C, Chen B, Hu Y, Wang S, Chen T, Xu M, et al. The Therapeutic Effects of Active Components from Food-Medicine Plants on Liver Fibrosis. Journal of Inflammation Research. 2026;Volume 19:1-20. doi:10.2147/jir.s573983

BibTeX
@article{Sun2026,
  author = {Sun, Caiyun and Chen, Binlong and Hu, Yaodong and Wang, Silu and Chen, Ting and Xu, Min and Gong, Qianyuan},
  title = {The Therapeutic Effects of Active Components from Food-Medicine Plants on Liver Fibrosis},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--20},
  doi = {10.2147/jir.s573983}
}
Kostenlos starten →